📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. (2022)

First Author: Antonelou M

Attributed to: MICA: Investigating the role of myeloperoxidase as a key mediator of renal damage in crescentic glomerulonephritis and reno-cardiac disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/03009742.2021.1926318

PubMed Identifier: 34474634

Publication URI: http://europepmc.org/abstract/MED/34474634

Type: Journal Article/Review

Volume: 51

Parent Publication: Scandinavian journal of rheumatology

Issue: 2

ISSN: 0300-9742